Clinical Trials Impact in Prince Edward Island's Agriculture
GrantID: 13907
Grant Funding Amount Low: $350,000
Deadline: Ongoing
Grant Amount High: $350,000
Summary
Explore related grant categories to find additional funding opportunities aligned with this program:
Health & Medical grants, Research & Evaluation grants, Science, Technology Research & Development grants.
Grant Overview
Priority Outcomes for Investigator-Initiated Mid-Phase Clinical Trials in Prince Edward Island
Prince Edward Island (PEI) is poised to leverage its unique strengths in natural product research to drive innovation in mid-phase clinical trials. The Island's distinct geography and demographics present opportunities for targeted research that can address specific health needs. The Prince Edward Island Health Research Advisory Committee, a key regional body, plays a vital role in guiding health research initiatives across the province.
Targeting Key Health Outcomes in PEI
The rural nature of PEI, combined with its aging population, creates a distinct set of health challenges that can be addressed through research into natural products. For instance, the Island's high rates of seasonal affective disorder and other mental health issues could be mitigated through studies on the efficacy of natural light therapy or other natural products. Similarly, PEI's significant lobster fishing industry has sparked interest in exploring the potential health benefits of seafood-derived compounds, which could lead to innovative treatments for various health conditions.
Research initiatives in PEI could focus on conditions prevalent in the region, such as cardiovascular disease, diabetes, and certain types of cancer. By emphasizing mid-phase clinical trials, researchers can bridge the gap between early-stage discoveries and larger-scale studies, ultimately contributing to the development of new treatments that can be tailored to the needs of the PEI population.
Aligning with Provincial Health Priorities
The Government of Prince Edward Island's Department of Health and Wellness has identified key health priorities that align with the goals of the Investigator-Initiated Mid-Phase Clinical Trials of Natural Products grant. These priorities include improving mental health services, enhancing primary care, and promoting healthy living. Research into natural products that can address these areas can have a direct impact on the health and wellbeing of PEI residents.
Moreover, the Island's compact size and integrated healthcare system make it an ideal location for conducting clinical trials that require close collaboration between researchers, healthcare providers, and community stakeholders. This environment can facilitate the translation of research findings into practical healthcare solutions.
Measuring Success in PEI
The success of mid-phase clinical trials in PEI will be measured by the advancement of promising natural products through the clinical trial pipeline, ultimately leading to improved health outcomes for Island residents. Key performance indicators will include the number of trials conducted, the number of participants enrolled, and the number of promising treatments that progress to later-stage trials or receive regulatory approval.
By focusing on these priority outcomes, researchers in PEI can make meaningful contributions to the field of natural product research while addressing the unique health needs of their community.
Q: How can researchers in Prince Edward Island access funding for mid-phase clinical trials of natural products? A: Researchers can apply for grants through the Banking Institution's Grants for Cooperative Agreement Applications for Investigator-Initiated Mid-Phase Clinical Trials of Natural Products program, with application budgets up to $350,000 per year in direct costs.
Q: What are the key health priorities in Prince Edward Island that could be addressed through natural product research? A: The Province's Department of Health and Wellness has identified mental health, primary care, and healthy living as key priorities, all of which could be addressed through research into natural products.
Q: How can the compact size of Prince Edward Island benefit clinical trials research? A: The Island's small size and integrated healthcare system facilitate close collaboration between researchers, healthcare providers, and community stakeholders, making it easier to conduct clinical trials and translate research findings into practical healthcare solutions.
Eligible Regions
Interests
Eligible Requirements
Related Grants
Nonprofit Grants to Examine the Etiology of Myalgic Encephalomyelitis
Grants are awarded on a rolling basis. Check the grant provider's website for application due da...
TGP Grant ID:
13913
Nonprofit Grants to Provide Design Scientific Rationale
Grants are awarded on a rolling basis. Check the grant provider's website for application due da...
TGP Grant ID:
13949
Grants to Justify Further Clinical Testing
The budget is limited to $350,000 direct costs per year in both the R61 and R33 phases. Application...
TGP Grant ID:
13951
Nonprofit Grants to Examine the Etiology of Myalgic Encephalomyelitis
Deadline :
2099-12-31
Funding Amount:
$0
Grants are awarded on a rolling basis. Check the grant provider's website for application due dates.Grants to Examine the Etiology, Diagnosis, Pat...
TGP Grant ID:
13913
Nonprofit Grants to Provide Design Scientific Rationale
Deadline :
2099-12-31
Funding Amount:
$0
Grants are awarded on a rolling basis. Check the grant provider's website for application due dates.Grants to Provide the Design Scientific Ration...
TGP Grant ID:
13949
Grants to Justify Further Clinical Testing
Deadline :
2099-12-31
Funding Amount:
$0
The budget is limited to $350,000 direct costs per year in both the R61 and R33 phases. Application budgets need to reflect the actual needs of the pr...
TGP Grant ID:
13951